CREDIT, because I work in the industry, I am worried by the knowledge that Big Pharma turn their backs on major investments all the time. In the grand scheme of things SA's investment in UNS does not tie them to anything or guarantee anything. Its encouraging and we are better with their money and relationship then without it. But for example, their investment is less then the cost of a facility I built a few years ago; which the parent company walked away from 12 months after completion! So...IF we lose Sanofi, where are we?!?!?!
I still hold which means despite the grind in SP I think the company is still in a reasonable position. Re the diversification, I wish they were doing it with with positive cashflow and not burning the cash they should be using to keep the doors open. I fear all parties are a little naive to the reality of having to close their doors due to cash burn and no orders. So I would like a little more conservatism from management. Sure Alan and co have bought loads of shares recently, but they also have paid themselves handsomely and run up something like 90million in losses so...think they could still walk away comfortably from a failed UNS.
If a few milestones come off later this year I am happy to pick up some more, but they have enough of my money tied up in this casino at present. :)
And Loogs, have a go, keeps me honest! I was a little lazy with my English in the above post...yes you are correct re filling. I did some consultancy work for Unilife back in the day around 2005ish so familiar with how they make the product. Obviously have not seen their current facility, so I could be wrong, but think those staffing numbers are a little conservative. But then again the numbers about new 120 staff required seems fanciful so the point is mute really.
UNS Price at posting:
52.5¢ Sentiment: Hold Disclosure: Held
